Co-CEOs appointed at Compugen
This article was originally published in Scrip
Executive Summary
Compugen (Israel), a drug and diagnostic product candidate discovery company, has appointed Dr Anat Cohen-Dayag and Martin Gerstel as co-CEOs. Dr Cohen-Dayag joined Compugen in 2002 and was most recently vice-president of R&D; Mr Gerstel joined the company in 1997 as chairman and served in that role until January, when he was appointed president and CEO.